SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unjha Formulations - Quaterly Results

08 Nov 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 38.07 millions as compared to Rs. 47.71 millions during the year-ago period.The Net Loss for the quarter ended September 2024 is Rs. -1.09 millions as compared to Net Loss of Rs. -1.16 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to -0.85% as compared to -0.95% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 38.07 47.71 -20.21 77.61 85.25 -8.96 185.08 131.85 40.37
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.85 -0.95 -10.53 6.36 1.10 478.18 5.89 4.63 27.21
Interest 0.02 0.01 100.00 0.03 0.05 -40.00 0.56 0.58 -3.45
PBDT -0.87 -0.96 -9.38 6.33 1.05 502.86 5.33 4.05 31.60
Depreciation 0.22 0.20 10.00 0.44 0.39 12.82 0.81 0.77 5.19
PBT -1.09 -1.16 -6.03 5.89 0.66 792.42 4.52 3.28 37.80
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.74 0.47 270.21
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.00
PAT -1.09 -1.16 -6.03 5.89 0.66 792.42 2.78 2.81 -1.07
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) -2.23 -1.99 12.13 8.19 1.29 535.11 3.18 3.51 -9.37

Unjha Formulations Share Price

20.95 0.00 (0.00%)
20-Apr-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1677.10
Dr. Reddys Lab 1238.25
Cipla 1238.70
Zydus Lifesciences 941.50
Lupin 2327.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×